Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease

Methods in Molecular Biology

Volumn 1213, Issue , 2014, Pages 331-339

  Gonzalez Rey, Elena ^a   Delgado, Mario ^a  

^a NONE

Author keywords

2,4,6 Trinitrobenzene sulfonic acid; Colitis; Crohn s disease; Dextran sulfate sodium; Mesenchymal stromal cells; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; DIARRHEA; DISEASE ACTIVITY; HISTOPATHOLOGY; HYPEREMIA; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; ULCER; ANIMAL; BIOLOGICAL THERAPY; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; INFLAMMATORY BOWEL DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; TREATMENT OUTCOME;

EID: 84929513871     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1453-1_27     Document Type: Article

References (15)

1. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205.
2. Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of infl ammation. Annu Rev Immunol 20:495–549.
3. Bouma G, Strober W (2003) The immunological and genetic basis of infl ammatory bowel disease. Nat Rev Immunol 3:521–533.
4. Ucelli A, Moreta L, Pistoia V (2008) Mesenchymal stem cells in Elath and disease. Nat Rev Immunol 8:726–736.
5. Gonzalez-Rey E, Anderson P, Gonzalez MA et al (2009) Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929–939.
6. Gonzalez MA, Gonzalez-Rey E, Rico L et al (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting infl ammatory and autoimmune responses. Gastro enterology 136:978–989.
7. Zhang Q, Shi S, Liu Y et al (2009) Mesenchymal stem cells derived from human gingival are capable of immunomodulatory functions and ameliorate infl ammation-related tissue destruction in experimental colitis. J Immunol 183: 7787–7798.
8. Castelo-Branco MT, Soares ID, Lopes DV et al (2012) Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the infl amed colon and ameliorate experimental colitis. PLoS One 7: e33360.
9. Kim HS, Shin TH, Lee BC et al (2013) Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Gastroenterology 145: 1392–1403.
10. Zani A, Cananzi M, Fascetti-Leon F et al (2014) Amniotic fl uid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 63:300–309.
11. Anderson P, Souza-Moreira L, Morell M et al (2013) Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut 62:1131–1141.
12. Parolini O, Souza-Moreira L, O’Valle F et al (2014) Therapeutic effect of human amniotic membrane-derived cells in experimental arthritis and other infl ammatory disorders. Arthritis Rheumatol. 66:327–339.
13. Duijvestein M, Vos AC, Roelofs H et al (2010) Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut 59:1662–1669.
14. Duijvestein M, Wildenberg ME, Welling MM et al (2011) Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29:1549–1558.
15. Ko IK, Kim BG, Awadallah A et al (2010) Targeting improves MSC treatment of infl ammatory bowel disease. Mol Ther 18:1365–1372.